Loading...
Envista Holdings Corp
NVST•NYSE
Healthcare
Medical - Equipment & Services
$18.45
$-0.42(-2.23%)
Envista Holdings Corp (NVST) Financial Performance & Statements
Review Envista Holdings Corp’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-2.18%
↓ 2.18%
Operating Income Growth
-3395.87%
↓ 3395.87%
Net Income Growth
-1016.37%
↓ 1016.37%
Operating Cash Flow Growth
22.05%
↑ 22.05%
Operating Margin
5.01%
↑ 5.01%
Gross Margin
54.14%
↑ 54.14%
Net Profit Margin
-44.90%
↓ 44.90%
ROE
-37.41%
↓ 37.41%
ROIC
2.73%
↑ 2.73%
Envista Holdings Corp (NVST) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Envista Holdings Corp stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $652.90M | $601.00M | $633.10M | $623.60M |
| Cost of Revenue | $280.40M | $283.70M | $303.20M | $265.60M |
| Gross Profit | $372.50M | $317.30M | $329.90M | $358.00M |
| Gross Profit Ratio | $0.57 | $0.53 | $0.52 | $0.57 |
| R&D Expenses | $26.70M | $25.50M | $23.60M | $23.30M |
| SG&A Expenses | $278.10M | $270.90M | $300.00M | $279.70M |
| Operating Expenses | $326.40M | $296.40M | $323.60M | $303.00M |
| Total Costs & Expenses | $606.80M | $578.50M | $626.80M | $568.60M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $9.90M | $11.90M | $11.70M | $12.90M |
| Depreciation & Amortization | -$300000.00 | $37.30M | $34.00M | $39.40M |
| EBITDA | $46.10M | $58.80M | -$1.12B | $94.40M |
| EBITDA Ratio | $0.07 | $0.10 | -$1.77 | $0.15 |
| Operating Income | $46.10M | $20.90M | $6.30M | $55.00M |
| Operating Income Ratio | $0.07 | $0.03 | $0.010 | $0.09 |
| Other Income/Expenses (Net) | -$9.60M | -$11.30M | -$12.80M | -$12.80M |
| Income Before Tax | $36.50M | $9.60M | -$1.17B | $35.30M |
| Income Before Tax Ratio | $0.06 | $0.02 | -$1.84 | $0.06 |
| Income Tax Expense | $35.30M | $1.40M | -$14.50M | $11.70M |
| Net Income | $1.20M | $8.20M | -$1.15B | $23.60M |
| Net Income Ratio | $0.002 | $0.01 | -$1.82 | $0.04 |
| EPS | $0.007 | $0.05 | -$6.69 | $0.14 |
| Diluted EPS | $0.007 | $0.05 | -$6.69 | $0.14 |
| Weighted Avg Shares Outstanding | $172.50M | $172.20M | $172.10M | $171.90M |
| Weighted Avg Shares Outstanding (Diluted) | $173.70M | $172.90M | $172.10M | $173.40M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan